the Prevalence of "Wearing-off" in Patients With Parkinson's Disease in Shanghai
Launched by XINHUA HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jan 1, 2019
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
PD patients would be randomly recruited into this investigation from around thirty hospital covering the 16 districts of Shanghai. The wearing off would be defined by two methods: the doctors' judgement or the WOQ-9 questionnaire which was a patient-determining tool. The investigation also includes the medicine, the severity of PD symptoms, the demographic factors. The study would be designed with the purpose of clarifying the prevalence of the "wearing-off" and its related influencing factors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have been clinical diagnosed with Parkinson's disease
- • have received stable anti-Parkinson's treatment before being recruited to the study.
- Exclusion Criteria:
- • being suspicious of atypical Parkinson syndrome or secondary Parkinson syndromes
- • have not received anti Parkinsonian treatment.
- • being combined with serious cognitive dysfunction or psychiatric symptoms
- • unable to complete the investigations.
About Xinhua Hospital, Shanghai Jiao Tong University School Of Medicine
Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a prominent clinical research institution renowned for its commitment to advancing medical science and patient care. Located in Shanghai, China, the hospital integrates clinical practice, education, and research, fostering innovation in various medical fields. With state-of-the-art facilities and a multidisciplinary team of experts, Xinhua Hospital conducts rigorous clinical trials aimed at evaluating new therapies and improving treatment outcomes. Its dedication to ethical standards and patient safety positions it as a leader in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhenguo Liu, Ph.D.
Study Chair
Xinhua hosipital affiliated to Shanghai Jiaotong university school of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials